Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer

NCT00043004 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

119

Enrollment

NETWORK

Sponsor class

Stopped low accrual

Conditions

Colorectal Cancer
Metastatic Cancer

Interventions

BIOLOGICAL: bevacizumab
DRUG: FOLFOX regimen
DRUG: fluorouracil
DRUG: leucovorin calcium
DRUG: oxaliplatin
PROCEDURE: conventional surgery
PROCEDURE: radiofrequency ablation

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC

Collaborators

[object Object]
[object Object]